158 related articles for article (PubMed ID: 37085701)
1. A mathematical modeling technique to understand the role of decoy receptors in ligand-receptor interaction.
Dey S; Ghosh A; Banerjee M
Sci Rep; 2023 Apr; 13(1):6523. PubMed ID: 37085701
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
3. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.
Roth W; Isenmann S; Nakamura M; Platten M; Wick W; Kleihues P; Bähr M; Ohgaki H; Ashkenazi A; Weller M
Cancer Res; 2001 Mar; 61(6):2759-65. PubMed ID: 11289159
[TBL] [Abstract][Full Text] [Related]
4. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
5. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
6. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
7. Serum concentration of soluble decoy receptor 3 in glioma patients before and after surgery.
Hwang SL; Lin CL; Cheng CY; Lin FA; Lieu AS; Howng SL; Lee KS
Kaohsiung J Med Sci; 2004 Mar; 20(3):124-7. PubMed ID: 15124896
[TBL] [Abstract][Full Text] [Related]
8. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
Front Immunol; 2022; 13():879648. PubMed ID: 35720343
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).
You RI; Chang YC; Chen PM; Wang WS; Hsu TL; Yang CY; Lee CT; Hsieh SL
Blood; 2008 Feb; 111(3):1480-8. PubMed ID: 18006694
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
[TBL] [Abstract][Full Text] [Related]
14. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
[TBL] [Abstract][Full Text] [Related]
16. Decoy receptor 3 promotes cell adhesion and enhances endometriosis development.
Tsai HW; Huang MT; Wang PH; Huang BS; Chen YJ; Hsieh SL
J Pathol; 2018 Feb; 244(2):189-202. PubMed ID: 29057478
[TBL] [Abstract][Full Text] [Related]
17. Decoy strategies: the structure of TL1A:DcR3 complex.
Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC
Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286
[TBL] [Abstract][Full Text] [Related]
18. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.
Wu NL; Huang DY; Hsieh SL; Hsiao CH; Lee TA; Lin WW
Biochim Biophys Acta; 2013 Oct; 1832(10):1538-48. PubMed ID: 23707413
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 is a prognostic factor in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
[TBL] [Abstract][Full Text] [Related]
20. Decoy Receptor 3 Promotes Preosteoclast Cell Death via Reactive Oxygen Species-Induced Fas Ligand Expression and the IL-1
Peng YJ; Peng CT; Lin YH; Lin GJ; Huang SH; Chen SJ; Sytwu HK; Cheng CP
Mediators Inflamm; 2020; 2020():1237281. PubMed ID: 32587467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]